
Panmure Liberum acts as Nominated Adviser, Joint Bookrunner and Joint Broker on Arecor Therapeutics’ £6.4 million fundraise
Jul 2024 News

Panmure Liberum acts as Joint Sponsor, Joint Financial Adviser and Joint Broker on Regional REIT’s £110.5 million equity fundraising
Jul 2024 News